CATWYLDA
LIVE

Serial Number

79370754

Owner

Autolus Limited

Attorney

Rebecca Liebowitz

Filing Date

Apr 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CATWYLDA Trademark

Serial Number: 79370754 • Registration: 7435622

CATWYLDA is a trademark filed by Autolus Limited on April 27, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Autolus Limited (7 trademarks)

The MediaWorks

Entity Type: 99

Trademark Details

Filing Date

April 27, 2023

Registration Date

July 9, 2024

Published for Opposition

April 23, 2024

Goods & Services

Medical and veterinary preparations for therapeutic purposes for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; medical preparations for cell therapy for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; medical preparations for gene therapy for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; medical preparations for cancer therapies for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; cells for medical or clinical use, namely cells featuring chimeric antigen receptors (CAR) and therapeutic preparations thereof for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; antibodies for medical purposes for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors, namely, culture media for cultivating and augmentation of human and animal cells; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes; pharmaceutical preparations for use in the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical and biological preparations for immunotherapy, including T cell therapy; vaccines

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 5, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 19, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 18, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 9, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Apr 30, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 10, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 10, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 16, 2024 CNSA
REFUSAL PROCESSED BY IB
Mar 4, 2024 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 29, 2024 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 13, 2024 RFCS
REFUSAL PROCESSED BY MPU
Feb 13, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 26, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jan 25, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 25, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 6, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 2, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 1, 2023 REPR